Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2021

May 14, 2021

SELL
$31.0 - $55.72 $620,000 - $1.11 Million
-20,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$37.09 - $48.97 $185,450 - $244,850
5,000 Added 33.33%
20,000 $742,000
Q4 2018

Feb 14, 2019

BUY
$37.97 - $60.16 $569,550 - $902,400
15,000 New
15,000 $694,000

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.